The effect of local administration of N-acetylcysteine in perforated rat tympanic membrane: An experimental study in myringosclerosis

Pharmacological Research

Volumn 45, Issue 1, 2002, Pages 5-9

  Özcan, Cengiz ^a,b   Polat, Gürbüz ^a   Görür, Kemal ^a   Ümit Talas, Derya ^a   Baǧdatoǧlu, Özlen ^a   Cinel, Ismail ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Lipid peroxidation; Myringosclerosis; N acetylcysteine; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; LIPID; MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; EARDRUM; EARDRUM PERFORATION; LIPID PEROXIDATION; MALE; MYRINGOSCLEROSIS; MYRINGOTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SCLEROSIS; STATISTICAL SIGNIFICANCE;

EID: 0036445498     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0906     Document Type: Article

References (46)

1. Sheehy JL, House WF. Tympanosclerosis. Arch Otolaryngol 1962; 76: 151-7.
2. Da Costa SS, Paparella MM, Schachern PA, Yoon TH, Kimberley BP. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 1992; 102: 1229-36.
3. Tos M, Stangerup S-E. Hearing loss in tympanoscleros is caused by grommets. Arch Otolaryngol Head Neck Surg 1989; 115: 931-5.
4. Duchert LG. Anatomy of the skull base, temporal bone, external ear, and middle ear. In: Otolaryngology Head and Neck Surgery. Cummings CW, Fredricson JM, Harker LA, Krause CJ, Schuller DE, Richarson MA, eds. St. Louis: Mosby, 1998: 2533-58.
5. Chole RA, Choo MJ. Chronic otitis media, mastoiditis, and petrositis. In: Otolaryngology Head and Neck Surgery. Cummings CW, Fredricson JM, Harker LA, Krause CJ, Schuller DE, Richarson MA, eds. St. Louis: Mosby, 1998: 3026-46.
6. Mattsson C, Marklund SL, Hellström S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 1997; 106: 513-8.
7. Tos M, Bonding P, Poulsen G. Tympanosclerosis of the drum in secretory otitis media after insertion of grommets. J Laryngol Otol 1983; 97: 489-96.
8. Möller P. Tympanosclerosis of the ear drum in secretory otitis media. Acta Otolaryngol Suppl 1984; 414: 171-7.
9. Ferlito A. Histopathogenesis of tympanosclerosis. J Laryngol Otol 1979; 93: 25-37.
10. Möller P. Tympanosclerosis of the eardrum in cleft palate patients. Acta Otolaryngol Suppl 1962; 76: 91-4.
11. Felding JU, Rassmussen JB, Lildholdt T. Gas composition of the normal and the ventilated middle ear cavity. Scand J Clin Lab Invest 1987; 47(Suppl. 186): 31-41.
12. Sáde J, Luntz M. Dynamic measurement of gas composition in the middle ear. II: Steady state value. Acta Otolaryngol (Stockh) 1993; 113: 353-7.
13. Mattsson C, Magnuson K, Hellström S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol 1995; 104: 625-32.
14. Deneke SM, Fanburg BL. Normobaric oxygen toxicity of the lung. N Eng J Med 1980; 303: 76-86.
15. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989; 140: 531-54.
16. Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology a chemist's perspective. Trends Pharmacol Sci 1995; 16: 18-22.
17. Lipton SA. Distinctive chemistries of NO-related species. Neurochem Int 1996; 29:111-4.
18. Spratley JE, Hellström SO, Mattsson CK, Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in rat. Ann Otol Rhinol Laryngol 2001; 110: 585-91.
19. Forséni M, Hansson GK, Bagger-Sjöbäck D, Hultcrantz M. An immunohistochemical study of inducible nitric oxide synthase in the rat middle ear, with reference to tympanosclerosis. Acta Otolaryngol (Stockh) 1999; 119: 577-82.
20. Forséni M, Bagger-Sjöbäck D, Hultcrantz M. A study of inflammatory mediators in the human tympanosclerotic middle ear. Arch Otolaryngol Head Neck Surg 2001; 127: 559-64.
21. Parks RR, Huang CC, Haddad J Jr. Superoxide dismutase in an animal model of otitis media. Eur Arch Otorhinolaryngol 1995; 252: 153-8.
22. Parks RR, Huang CC, Haddad J Jr. Middle ear catalase distribution in an animal model of otitis media. Eur Arch Otorhinolaryngol 1996; 253: 445-9.
23. Haddad J Jr. Lipoperoxidation as a measure of free radical injury in otitis media. Laryngoscope 1998; 108: 524-30.
24. Parks RR, Huang CC, Haddad J Jr. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 1994; 104: 1389-92.
25. Kharazmi A, Nielsen H, Schiötz PO. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol 1988; 10: 39-46.
26. Pearson JP, Fitzgerald JE, Green CGR, Birchall JP, Stafford FW. Mucolytic agents for glue ear. Lancet 1985; ii: 674-5.
27. Mattsson C, Hellström S. Inhibition of the development of myringosclerosis by local administration of fenspiride, an anti-inflammatory drug. Eur Arch Otorhinolaryngol 1997; 254: 425-9.
28. Karasu Ç, Ozansoy G, Bozkurt O, Erdoǧan D, Ömeroǧlu S. Antioxidant and trygiceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozosin-diabetic rats. Metabolism 1997; 46: 872-9.
29. Spreng D, Sigrist N, Schweighauser A, Busato A, Schawalder P. Endogenous nitric oxide production in canine osteoarthritis: Detection in urine, serum, and synovial fluid specimens. Vet Surg 2001; 30: 191-9.
30. Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 2000; 80: 1905-14.
31. Kamada Y, Nakatsuka M, Asagiri K, Noguchi S, Habara T, Takata M, Kudo T. GnRH agonist-suppressed expression of nitric oxide synthases and generation of peroxynitrite in adenomyosis. Hum Reprod 2000; 15: 2512-9.
32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
33. Yagi K. Simple procedure for specific enzyme of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998; 108: 107-10.
34. Mattsson C, Johansson C, Hellstrom S. Myringosclerosis develops within 9h of myringotomy. ORL J Otorhinolaryngol Relat Spec 1999; 61: 31-5.
35. Sorensen H, True O. Histology of tympanosclerosis. Acta Otolaryngol (Stockh) 1971; 73: 18-26.
36. Mann W, Beck C, Schaefer HE. The significance of calcium antagonist in rat experimental tympanosclerosis. Arch Otorhinolaryngol 1987; 243: 382-6.
37. Mattson C, Magnuson K, Hellström S. Myringotomy: A prerequisite for the development of myringosclerosis? Laryngoscope 1998; 108: 102-5.
38. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
39. Thiemermann C. The role of the L-arginine: Nitric oxide pathway in circulatory shock. Adv Pharmacol 1994; 28: 45-79.
40. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3: 2-32.
41. Kampf C, Roomans GM. Effects of hypochlorite on cultured respiratory epithelial cells. Free Radic Res 2001; 34: 499-511.
42. Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, Giovannini F, Tomasi A, Iannone A. N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 2001; 5: 349-60.
43. Pepperl S, Dorger M, Ringel F, Kupatt C, Krombach F. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: Role of AP-1 and NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2001; 280: 905-13.
44. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998; 83: 916-22.
45. Ovesen T, Paaske PB, Elbroend O. Local application of N-acetylcysteine in secretory otitis media in rabbits. Clin Otolaryngol 1992; 17: 327-31.
46. Ovesen T, Gaihede M, Ledet T. The effect of N-acetylcysteine on the in vitro growth of normal rabbit middle ear fibroblasts. Clin Otolaryngol 1993; 18: 400-5.